• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ICU MEDICAL DE MEXICO, S. DE R.L. DE C.V. CHEMOLOCK¿ PORT; CLOSED ANTINEOPLASTIC AND HAZARDOUS DRUG RECONSTITUTION AND TRANSFER SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ICU MEDICAL DE MEXICO, S. DE R.L. DE C.V. CHEMOLOCK¿ PORT; CLOSED ANTINEOPLASTIC AND HAZARDOUS DRUG RECONSTITUTION AND TRANSFER SYSTEM Back to Search Results
Model Number CL3520
Device Problems Crack (1135); Fluid/Blood Leak (1250)
Patient Problems Chemical Exposure (2570); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/01/2022
Event Type  malfunction  
Event Description
The event occurred on an unspecified date and involved a 40" (102 cm) appx 5.2 ml, admin set w/2 chemolock¿ w/red cap, 20 drop in-line drip chamber, bag hanger.The customer reported that they had a chemo spill due to a cracked secondary set.There was no report of patient involvement or patient harm.
 
Manufacturer Narrative
The device has been received.Pending investigation.
 
Event Description
Additional information was received from the customer stating the actual device involved was an alaris infusion set with a chemolock¿ port attached at the end.The customer stated that the device cracked where the line sits inside the pump, where the soft plastic sits inside the pump meets the hard plastic, at either the top or the bottom.This caused the pump to get wet and shut down.The chemo came into contact with the patient.There was patient involvement, however no report of patient harm.
 
Manufacturer Narrative
Received one used list #cl2100, chemolock¿ port; lot #unknown, one bd alaris pump set, and one unknown catheter and hub were received and visually inspected.As received, no visible damage or anomalies were identified.Connected as received, the returned samples were leak tested through the chemolock port.Leakage occurred through a tear in the bd alaris tubing.The chemolock port was disconnected from the alaris set and leak tested.No damage, anomalies or leaks were identified on the chemolock port.The reported complaint of leakage from the chemolock port was not confirmed.The leakage observed occurred from a tear in the bd alaris tubing (non-icu medical device).The probable cause of the tear is unknown.A dhr lot # review could not be conducted because no lot number(s) was/were identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CHEMOLOCK¿ PORT
Type of Device
CLOSED ANTINEOPLASTIC AND HAZARDOUS DRUG RECONSTITUTION AND TRANSFER SYSTEM
Manufacturer (Section D)
ICU MEDICAL DE MEXICO, S. DE R.L. DE C.V.
avenida cuarzo no. 250
ensenada, b.cfa. 22790
MX  22790
Manufacturer Contact
michael visocnik
600 n. field dr.
lake forest, IL 60045
2247062300
MDR Report Key13685775
MDR Text Key290091921
Report Number9617594-2022-00047
Device Sequence Number1
Product Code ONB
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
K131549
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 02/10/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/08/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberCL3520
Device Catalogue NumberCL2100
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/24/2022
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/09/2022
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
UNSPECIFIED ALARIS INFUSION SET; UNSPECIFIED CHEMOTHERAPY, UNK MFR
-
-